Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Langerbeins, Petra
51  Ergebnisse:
Personensuche X
?
1

Hybrid immunity to SARS‐CoV‐2 in patients with chronic lymp..:

Mellinghoff, Sibylle C. ; Robrecht, Sandra ; Sprute, Rosanne...
European Journal of Haematology.  112 (2024)  5 - p. 788-793 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Infections in patients with chronic lymphocytic leukemia tr..:

Langerbeins, Petra ; Giza, Adam ; Robrecht, Sandra...
American Journal of Hematology.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Bendamustine, followed by obinutuzumab and idelalisib in ch..:

Cramer, Paula ; von Tresckow, Julia ; Fink, Anna‐Maria...
American Journal of Hematology.  99 (2024)  6 - p. 1192-1195 , 2024
Link: https://doi.org/10.1002/..
 
?
4

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Langerbeins, Petra ; Robrecht, Sandra ; Nieper, Pascal...
HemaSphere.  7 (2023)  S3 - p. e9488123 , 2023
Link: https://doi.org/10.1097/..
 
?
5

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:

Yosifov, Deyan ; von Tresckow, Julia ; Giza, Adam...
HemaSphere.  7 (2023)  S3 - p. e14818fb , 2023
Link: https://doi.org/10.1097/..
 
?
6

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:

Deyan Yosifov ; Julia von Tresckow ; Adam Giza...
http://journals.lww.com/10.1097/01.HS9.0000969392.14818.fb.  , 2023
Link: https://doi.org/10.1097/..
 
?
7

Early treatment with FCR versus watch and wait in patients ..:

Herling, Carmen D ; Cymbalista, Florence ; Groß-Ophoff-Müller, Carolin...
https://www.nature.com/articles/s41375-020-0747-7#Sec13.  , 2023
Link: https://doi.org/10.18725..
 
?
8

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Langerbeins, Petra ; Robrecht, Sandra ; Nieper, Pascal...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428394/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

P622: GENETIC MARKERS AND OUTCOME OF CLL PATIENTS IN COMBIN..:

Yosifov, Deyan ; von Tresckow, Julia ; Giza, Adam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429433/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

S200: IBRUTINIB VERSUS PLACEBO IN PATIENTS WITH ASYMPTOMATI..:

Petra Langerbeins ; Sandra Robrecht ; Pascal Nieper...
http://journals.lww.com/10.1097/01.HS9.0000967712.94881.23.  , 2023
Link: https://doi.org/10.1097/..
 
?
11

COVID-19 among fit patients with CLL treated with venetocla..:

Fürstenau, Moritz ; Langerbeins, Petra ; De Silva, Nisha...
http://dx.doi.org/10.18725/OPARU-51223.  , 2023
Link: https://doi.org/10.18725..
 
?
12

SARS-CoV-2-specific cellular response following third COVID..:

Mellinghoff, Sibylle C. ; Mayer, Leonie ; Robrecht, Sandra...
Haematologica.  107 (2022)  10 - p. 2480-2484 , 2022
Link: https://doi.org/10.3324/..
 
?
13

72/m mit Zufallsbefund einer Lymphozytose: Vorbereitung auf..:

Langerbeins, Petra ; Eichhorst, Barbara ; Hallek, Michael
Der Onkologe.  28 (2022)  S2 - p. 137-143 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Sequential treatment with bendamustine, obinutuzumab (GA101..:

von Tresckow, Julia ; Cramer, Paula ; Robrecht, Sandra...
Leukemia.  36 (2022)  8 - p. 2125-2128 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Sequential treatment with bendamustine, obinutuzumab (GA101..:

von Tresckow, Julia ; Cramer, Paula ; Robrecht, Sandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343250/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15